作者: Kristiina Iljin , Matthias Nees , Mari Björkman , Olli Kallioniemi
DOI:
关键词:
摘要: The invention relates to a method for treating ERG-positive prostate cancer patients with an agent counteracting one or more ERG-associated genes and/or manipulating of ERG-related pathways, optionally in combination androgen deprivation therapy. Furthermore, the concerns methods screening which may benefit from said treatment, assessing efficacy therapy patient, progression selecting be tested usefulness treatment cancer, and carcinogenic potential agent.